Frontiers in Pharmacology | Drugs Outcomes Research and Policies

Original Research

Published on 21 Feb 2025

Impacts of Chinese national centralized volume-based procurement policy targeting meropenem on prescription of designated antimicrobials for inpatients: an interrupted time series analysis

in Drugs Outcomes Research and Policies

Zhi-Hang Lin
Can-Ming Wang
Li-Li Cai

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1458792

Original Research

Accepted on 20 Feb 2025

Differences in Risk Factors for Mortality between T2N1M0 and T3N0M0 Lobular Breast Cancer Patients: A Comparative Study

in Drugs Outcomes Research and Policies

Longjie Xia
Chunxin Qin
Wei Chen
Kang Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1550081

Original Research

Published on 19 Feb 2025

Association between hyperuricemia and all-cause mortality in people taken Statins: a retrospective cohort study

in Drugs Outcomes Research and Policies

Bin Zhu
Zijun He
Mingfen Wu
Jiping Huo
Zhigang Zhao
Wei Guo
Li Yang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1533709

164 views

Original Research

Accepted on 17 Feb 2025

Targeting Glycolysis in Esophageal Squamous Cell Carcinoma: Single-Cell and Multi-Omics Insights for Risk Stratification and Personalized Therapy

in Drugs Outcomes Research and Policies

Yan Wang
Yunjie Shi
Xiao Hu
Chenfang Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1559546

Original Research

Published on 17 Feb 2025

Impact of the national health insurance coverage policy on mecapegfilgrastim utilization for chemoradiotherapy-induced neutropenia in cancer patients in China: a retrospective real-world analysis

in Drugs Outcomes Research and Policies

Wenqing Fang
Jizhong He
Ying Wang
Yulei Zhu
Xiaodan Qian
Dan Su
Jinhong Gong
Jingjing Shang
Yuan He
Hong Wu

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1546261

158 views

Review

Accepted on 14 Feb 2025

Effects of perioperative anesthetics on the postoperative prognosis of patients undergoing surgery for cervical cancer

in Drugs Outcomes Research and Policies

Linyan Deng
Tingting Wang
Qiaofeng Zhang
Shaofang Shu
Xiangdong Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1536663

Original Research

Accepted on 13 Feb 2025

Undergraduate Pharmacy Students' Preference for Case-Based Learning: A Discrete Choice Experiment in China

in Drugs Outcomes Research and Policies

Zhibo Guo
Yuxing He
Jianzhou Yan

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1529492

Original Research

Published on 13 Feb 2025

Time in the therapeutic range, bleeding event, and their determinants in older patients with atrial fibrillation on warfarin in Ethiopia: multicenter cross-sectional study

in Drugs Outcomes Research and Policies

Zenaw Debasu Addisu
Desalegn Getnet Demsie
Chernet Tafere
Taklo Simeneh Yazie
Destaw Endeshaw
Bereket Bahiru Tefera
Malede Berihun
Dessale Abate Beyene

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1541592

188 views

Brief Research Report

Published on 13 Feb 2025

Consumers’ expected information search behavior for a pharmaceutical treatment

in Drugs Outcomes Research and Policies

Yifei Liu
Jack E. Fincham
Morgan L. Sperry

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1466352

137 views

Original Research

Accepted on 11 Feb 2025

Clinical-Pharmaceutical Assessment of Medication CDSS-alerts: Content Appropriateness and Patient Relevance in Clinical Practice

in Drugs Outcomes Research and Policies

Jacqueline Bauer
Marika Busse
Sonja Koch
Marina Schmid
Julia Sommer
Martin F. Fromm
Frank Dörje

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1510425

Original Research

Published on 11 Feb 2025

Profile of STING agonist and inhibitor research: a bibliometric analysis

in Drugs Outcomes Research and Policies

Xuemei Wang
Qian Wang
Yidan Gao
Lijuan Jiang
Lingli Tang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1528459

251 views

Original Research

Published on 11 Feb 2025

Exploring information technology utilization and needs in community pharmacies: a cross-sectional survey in Shanghai, China

in Drugs Outcomes Research and Policies

Qin Li
Zhao Jin
Yun Liao
Huihua Dai
Jie Meng
Ling Li

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1554141

176 views

Original Research

Accepted on 10 Feb 2025

Post-Marketing Safety Re-evaluation of Placental Peptide Injection in China: A Large-Scale Multicenter Real-World Study

in Drugs Outcomes Research and Policies

Liguang Duan
Feiyue An
Chen Tian
Wen Yan
Jie Chen
Hongyin Zhang
Xiaoguang Liu
Lingjiao Wang
Zhuo Zhang
Binliang Tong

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1541005

Perspective

Accepted on 10 Feb 2025

What role for real-world evidence in market access of biosimilars?

in Drugs Outcomes Research and Policies

Steven Simoens
Catherine M Lockhart
Delphine F Courmier

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1538866

Systematic Review

Accepted on 10 Feb 2025

Factors Influencing the Cost-effectiveness of Novel Oral Anticoagulants Compared to Vitamin K Antagonists in Patients with Atrial Fibrillation: A Systematic Review

in Drugs Outcomes Research and Policies

Yan Li
Xintian Wang
Aixia Ma
Pingyu Chen
Hongchao Li

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1441754

Technology and Code

Accepted on 10 Feb 2025

Integrating WHO's Digital Adaptation Kit for Antenatal Care into BornFyne-PNMS: Insights from Cameroon

in Drugs Outcomes Research and Policies

Miriam Nkangu
Brice Tangang
Arthur Pessa
Donald Weledji
Pamela Obegu
Mwenya Kasonde
Valery Ngo
Franck Wanda
Ronald Gobina
Odette Kibu

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1474999

Navigation group

Articles

Impacts of Chinese national centralized volume-based procurement policy targeting meropenem on prescription of designated antimicrobials for inpatients: an interrupted time series analysis

Differences in Risk Factors for Mortality between T2N1M0 and T3N0M0 Lobular Breast Cancer Patients: A Comparative Study

Association between hyperuricemia and all-cause mortality in people taken Statins: a retrospective cohort study

Targeting Glycolysis in Esophageal Squamous Cell Carcinoma: Single-Cell and Multi-Omics Insights for Risk Stratification and Personalized Therapy

Impact of the national health insurance coverage policy on mecapegfilgrastim utilization for chemoradiotherapy-induced neutropenia in cancer patients in China: a retrospective real-world analysis

Effects of perioperative anesthetics on the postoperative prognosis of patients undergoing surgery for cervical cancer

Undergraduate Pharmacy Students' Preference for Case-Based Learning: A Discrete Choice Experiment in China

Time in the therapeutic range, bleeding event, and their determinants in older patients with atrial fibrillation on warfarin in Ethiopia: multicenter cross-sectional study

Consumers’ expected information search behavior for a pharmaceutical treatment

Clinical-Pharmaceutical Assessment of Medication CDSS-alerts: Content Appropriateness and Patient Relevance in Clinical Practice

Profile of STING agonist and inhibitor research: a bibliometric analysis

Exploring information technology utilization and needs in community pharmacies: a cross-sectional survey in Shanghai, China

Post-Marketing Safety Re-evaluation of Placental Peptide Injection in China: A Large-Scale Multicenter Real-World Study

What role for real-world evidence in market access of biosimilars?

Factors Influencing the Cost-effectiveness of Novel Oral Anticoagulants Compared to Vitamin K Antagonists in Patients with Atrial Fibrillation: A Systematic Review

Integrating WHO's Digital Adaptation Kit for Antenatal Care into BornFyne-PNMS: Insights from Cameroon